News Amicogen, Inc.

Equities

A092040

KR7092040005

End-of-day quote Korea S.E. Other stock markets 03:30:00 20/05/2024 am IST			5-day change	1st Jan Change
7,210 ^KRW	-2.44%		-0.41%	-4.63%

20/03	Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Beyond Cells announced that it has received KRW 3 billion in funding from Amicogen, Inc.	15/23/15	CI
Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Lysando Ag and Amicogen Inc. Sign General Development Agreement	18/22/18	CI
Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Amicogen, Inc. announced that it expects to receive KRW 40 billion in funding	18/22/18	CI
Amicogen, Inc. announced that it expects to receive KRW 40 billion in funding	18/22/18	CI
Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Amicogen, Inc. announced that it has received KRW 8.7 billion in funding	11/22/11	CI
Amicogen, Inc. announced that it expects to receive KRW 8.7 billion in funding	09/22/09	CI
Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22/22/22	CI
Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15	CI
Amicogen, Inc. completed the acquisition of 30% stake in BIFIDO Co., Ltd from a group of shareholders.	14/21/14	CI
Bio Works Technologies : Amicogen Inc enters into agreement to divest its ownership in Bio-Works	10/21/10	AQ
Amicogen, Inc. announced that it has received KRW 22.2724863 billion in funding from Lysando AG	02/21/02	CI
Amicogen, Inc. agreed to acquire a 30% stake in BIFIDO Co., Ltd from a group of shareholders for KRW 60.1 billion.	21/21/21	CI
Amicogen, Inc. agreed to acquire 8% stake in Lysando AG for KRW 28 billion.	15/21/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Amicogen, Inc.

Equities

A092040

KR7092040005

Summary

Filters